• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CD11c+ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice

tetano

Editor, Senior Moderator
Eur J Immunol. 2013 Nov 12. doi: 10.1002/eji.201343587. [Epub ahead of print]
CD11c+ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.
Richert LE, Rynda-Apple A, Harmsen AL, Han S, Wiley JA, Douglas T, Larson K, Morton RV, Harmsen AG.
Source

Department of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Abstract

Recent evidence suggests that an individual's unique history and sequence of exposures to pathogens and antigens may dictate downstream immune responses to disparate antigens. We show that the intranasal delivery of non-replicative virus-like particles (VLPs), which bear structural but no antigenic similarities to respiratory pathogens, acts to prime the lungs of both C56BL/6 and BALB/c mice, facilitating heightened and accelerated primary immune responses to high-dose influenza challenge, thus providing a non-pathogenic model of innate imprinting. These responses correspond closely to those observed following natural infection with the opportunistic fungus, Pneumocystis murina, and are characterized by accelerated antigen processing by dendritic cells (DCs) and alveolar macrophages (AMs), an enhanced influx of cells to the local tracheobronchial lymph node (TBLN), and early upregulation of T-cell co-stimulatory/adhesion molecules. CD11c+ cells which have been directly exposed to VLPs or Pneumocystis are necessary in facilitating enhanced clearance of influenza virus, and the repopulation of the lung by Ly-6C+ precursors relies on CCR2 expression. Thus, immune imprinting 72 hours after VLP-, or 2 weeks after Pneumocystis-priming is CCR2-mediated and results from the enhanced antigen processing, maturation, and trafficking abilities of DCs and AMs, which cause accelerated influenza-specific primary immune responses and result in superior viral clearance. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.
KEYWORDS:

CCR2, Dendritic cell, Influenza, Innate imprinting, Pneumocystis murina

PMID:
24222381
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24222381
 
Back
Top Bottom